146 related articles for article (PubMed ID: 33316539)
1. Relationship between morular metaplasia and squamous differentiation in endometrial carcinoma.
Travaglino A; Raffone A; Gencarelli A; Raimondo D; Moretta P; Pignatiello S; Granata M; Seracchioli R; Zullo F; Insabato L
Pathol Res Pract; 2021 Jan; 217():153307. PubMed ID: 33316539
[TBL] [Abstract][Full Text] [Related]
2. Does endometrial morular metaplasia represent odontogenic differentiation?
Travaglino A; Raffone A; Russo D; Guadagno E; Pignatiello S; Moretta P; Zullo F; Del Basso De Caro M; Insabato L; Mascolo M
Virchows Arch; 2021 Sep; 479(3):607-616. PubMed ID: 33666744
[TBL] [Abstract][Full Text] [Related]
3. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2.
Houghton O; Connolly LE; McCluggage WG
Histopathology; 2008 Aug; 53(2):156-65. PubMed ID: 18752499
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation.
Wani Y; Notohara K; Saegusa M; Tsukayama C
Hum Pathol; 2008 Jul; 39(7):1072-9. PubMed ID: 18495206
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of squamous differentiation and morular metaplasia in uterine endometrioid adenocarcinoma.
Blanco LZ; Heagley DE; Lee JC; Gown AM; Gattuso P; Rotmensch J; Guirguis A; Dewdney S; Bitterman P
Int J Gynecol Pathol; 2013 May; 32(3):283-92. PubMed ID: 23518912
[TBL] [Abstract][Full Text] [Related]
9. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
10. P504S/alpha-methylacyl-CoA racemase, HNF1β and napsin A in morular metaplasia and clear cell carcinoma of the endometrium: An immunohistochemical analysis.
Arciuolo D; Travaglino A; Raffone A; Santoro A; Inzani F; Piermattei A; Bui L; Scaglione G; D'Alessandris N; Valente M; Fulgione C; Guida M; Mollo A; Insabato L; Zannoni GF
Pathol Res Pract; 2022 Aug; 236():153953. PubMed ID: 35696768
[TBL] [Abstract][Full Text] [Related]
11. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
12. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
[TBL] [Abstract][Full Text] [Related]
13. Shadow cell differentiation from squamoid morule in endometrial adenoacanthoma.
Nakamura T
Int J Clin Exp Pathol; 2015; 8(10):13120-4. PubMed ID: 26722510
[TBL] [Abstract][Full Text] [Related]
14. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63.
O'Connell JT; Mutter GL; Cviko A; Nucci M; Quade BJ; Kozakewich HP; Neffen E; Sun D; Yang A; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):30-6. PubMed ID: 11136566
[TBL] [Abstract][Full Text] [Related]
15. Morules in endometrial carcinoma and benign endometrial lesions differ from squamous differentiation tissue and are not infected with human papillomavirus.
Chinen K; Kamiyama K; Kinjo T; Arasaki A; Ihama Y; Hamada T; Iwamasa T
J Clin Pathol; 2004 Sep; 57(9):918-26. PubMed ID: 15333650
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy.
Wright MF; Fitzlaff S; Wyeth A; Zaragoza-Watkins M; Podoll MB; Quick CM; Watkins JC
Int J Gynecol Pathol; 2021 May; 40(3):240-247. PubMed ID: 32897964
[TBL] [Abstract][Full Text] [Related]
17. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ
Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884
[TBL] [Abstract][Full Text] [Related]
18. Do estrogen, progesterone, P53 and Ki67 receptor ratios determined from curettage materials in endometrioid-type endometrial carcinoma predict lymph node metastasis?
Gülseren V; Kocaer M; Özdemir İA; Çakır İ; Sancı M; Güngördük K
Curr Probl Cancer; 2020 Feb; 44(1):100498. PubMed ID: 31395281
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
Leibl S; Gogg-Kammerer M; Sommersacher A; Denk H; Moinfar F
Am J Surg Pathol; 2005 Mar; 29(3):347-53. PubMed ID: 15725803
[TBL] [Abstract][Full Text] [Related]
20. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Alkushi A; Köbel M; Kalloger SE; Gilks CB
Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
